Anthony J Weier

Array ( [id] => 4033945 [patent_doc_number] => 05856180 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Immortalization of dendritic cells with V-MYC oncogene' [patent_app_type] => 1 [patent_app_number] => 8/549666 [patent_app_country] => US [patent_app_date] => 1995-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 18 [patent_no_of_words] => 8079 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856180.pdf [firstpage_image] =>[orig_patent_app_number] => 549666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4018293 [patent_doc_number] => 05925333 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Methods for modulation of lipid uptake' [patent_app_type] => 1 [patent_app_number] => 8/559505 [patent_app_country] => US [patent_app_date] => 1995-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15725 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925333.pdf [firstpage_image] =>[orig_patent_app_number] => 559505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3999832 [patent_doc_number] => 05858782 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Functional human hematopoietic cells' [patent_app_type] => 1 [patent_app_number] => 8/557991 [patent_app_country] => US [patent_app_date] => 1995-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 3226 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858782.pdf [firstpage_image] =>[orig_patent_app_number] => 557991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4000693 [patent_doc_number] => 05986170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Murine model for human carcinoma' [patent_app_type] => 1 [patent_app_number] => 8/556659 [patent_app_country] => US [patent_app_date] => 1995-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5454 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/986/05986170.pdf [firstpage_image] =>[orig_patent_app_number] => 556659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4058125 [patent_doc_number] => 05863904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Methods for treating cancers and restenosis with P21' [patent_app_type] => 1 [patent_app_number] => 8/533942 [patent_app_country] => US [patent_app_date] => 1995-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 6023 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863904.pdf [firstpage_image] =>[orig_patent_app_number] => 533942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051916 [patent_doc_number] => 05932556 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Methods and compositions for regulation of CD28 expression' [patent_app_type] => 1 [patent_app_number] => 8/529878 [patent_app_country] => US [patent_app_date] => 1995-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 15 [patent_no_of_words] => 18153 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932556.pdf [firstpage_image] =>[orig_patent_app_number] => 529878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3812709 [patent_doc_number] => 05811634 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Transgenic mammal encoding ornithine decarboxylase' [patent_app_type] => 1 [patent_app_number] => 8/527227 [patent_app_country] => US [patent_app_date] => 1995-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 7645 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811634.pdf [firstpage_image] =>[orig_patent_app_number] => 527227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4078286 [patent_doc_number] => 05965787 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'HLA-DRBI peptides with specific binding affinity for HLA-DQ molecules: prevention and treatment of rheumatoid arthritis' [patent_app_type] => 1 [patent_app_number] => 8/521871 [patent_app_country] => US [patent_app_date] => 1995-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 25 [patent_no_of_words] => 13761 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965787.pdf [firstpage_image] =>[orig_patent_app_number] => 521871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3804272 [patent_doc_number] => 05811089 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Pharmaceutical preparation based on fetal suspension and methods of treating acquired immune deficiency syndrome (HIV injection)' [patent_app_type] => 1 [patent_app_number] => 8/505236 [patent_app_country] => US [patent_app_date] => 1995-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10706 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811089.pdf [firstpage_image] =>[orig_patent_app_number] => 505236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3738650 [patent_doc_number] => 05753505 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Neuronal progenitor cells and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/499093 [patent_app_country] => US [patent_app_date] => 1995-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 8 [patent_no_of_words] => 13914 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753505.pdf [firstpage_image] =>[orig_patent_app_number] => 499093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4031390 [patent_doc_number] => 05994315 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Low adenosine agent, composition, kit and method for treatment of airway disease' [patent_app_type] => 1 [patent_app_number] => 8/474497 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7947 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994315.pdf [firstpage_image] =>[orig_patent_app_number] => 474497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407433 [patent_doc_number] => 06172047 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Method of screening candidate protective, potentiating, or inhibiting substances' [patent_app_type] => 1 [patent_app_number] => 8/483533 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17428 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172047.pdf [firstpage_image] =>[orig_patent_app_number] => 483533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237772 [patent_doc_number] => 06075181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Human antibodies derived from immunized xenomice' [patent_app_type] => 1 [patent_app_number] => 8/486857 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 9279 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075181.pdf [firstpage_image] =>[orig_patent_app_number] => 486857 [rel_patent_id] =>[rel_patent_doc_number] =>)